![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 24, 21666-21674, June 14, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
, andFrom the Department of Biology, University of Rome Tor Vergata, Via della Ricerca Scientifica, Rome 00133, Italy
Received for publication, October 10, 2001, and in revised form, February 14, 2002
| |
ABSTRACT |
|---|
|
|
|---|
We have designed a repertoire of
107 different SH3 domains by grafting the residues
that are represented in the binding surfaces of natural SH3 domains
onto the scaffold of the human Abl-SH3 domain. This phage-displayed
library was screened by affinity selection for SH3 domains that bind to
the synthetic peptides, APTYPPPLPP and LSSRPLPTLPSP, which are peptide
ligands for the human Abl or Src SH3 domains, respectively. By
characterizing the isolates, we have observed that as few as two or
three amino acid substitutions lead to dramatic changes in recognition
specificity. We propose that the ability to shift recognition
specificity with a small number of amino acid replacements is an
important evolutionary characteristic of protein binding modules.
Furthermore, we have used the information obtained by these in
vitro evolution experiments to generate a scoring matrix that
evaluates the probability that any SH3 domain binds to the peptide
ligands for the Abl and Src SH3 domains. A table of predictions for the
28 SH3 domains of baker's yeast is presented.
Protein interaction inside the cell is often mediated by families
of protein modules that occur in proteins of very different function
(1). Each module is specialized in recognizing specific features of the
protein surface: for example, SH3 domains bind to peptides that fold
into a poly-proline helix, SH2 domains have affinity for peptides
containing phosphorylated tyrosines, and PDZ domains recognize
carboxyl-terminal peptides (1-4). Within each type of module,
molecular recognition is modulated by changing the chemical
characteristics of the domain surface, which in turn determines the
preference for different contexts of the common target structural theme
(for instance the poly-proline helix for SH3 domains).
Some reports have suggested the existence of a molecular recognition
code for protein interaction modules (5). Although everyone accepts
that, ultimately, protein recognition must be based on the fundamental
laws of physics and chemistry, simple rules like "residue A at
position x in the domain calls for residue B at position
y in the ligand" have been proposed (6-10). Most of these
rules have had limited success in accurately predicting protein-protein
interactions. The prospect of being able to crack some sort of
recognition code relies on the assumption that the solutions to the
problem of binding a specific domain are concentrated in a small
cluster in the sequence/structure space. Alternatively, the problem of
finding the consensus ligand for any receptor domain would
change into the more difficult problem of finding "all" the
consensus sequences that share the potential of binding to that receptor.
Another intriguing issue is why relatively few scaffolds have been
selected during evolution for the purpose of maintaining a rather
complex protein interaction network. Apparently, once a solution for
binding to a specific surface feature is found, that solution is
explored extensively to find new binding specificities. An advantageous
characteristic of a protein recognition domain would be the ability to
modify recognition specificity by a limited number of changes of its
primary sequence without extensive structural rearrangements and
without the need to explore long evolutionary pathways encompassing
non-functional states. This would permit, by accumulation of a small
number of mutations, the growth of a functionally large natural
repertoire, wherefrom the selection of new binding specificity could be possible.
To obtain evidence of this postulated malleability of protein
recognition modules and of the elusive recognition code, we chose to
focus on SH3 domains, because they represent the most numerous family
of protein interaction modules in eukaryotic genomes (11) and because
the structures of several SH3 domains, both isolated and in complex
with their targets, have been determined (reviewed in Refs. 12-14).
SH3 domains bind to their targets by accommodating a peptide segment,
which is folded into a poly-proline II helix, into a binding cleft
formed by three molecular pockets of their surface. Two of the pockets
are hydrophobic and host the PXXP motif, which is
considered the signature of SH3 ligands, whereas the third is
negatively charged and determines the specificity and the orientation
of the ligand by hosting a positively charged residue that either
precedes or follows the PXXP motif (15-17). Peptides
characterized by the RXXPXXP motif bind in an
orientation called "class I" orientation, whereas peptides
displaying the PXXPXR motif bind in the opposite
orientation and are termed "class II." A third class of ligands,
exemplified by peptide ligands of the Abl SH3 domain, do not contain a
positively charged residue, are characterized by the consensus
PX@XXPXXP (@ = aromatic residue), and bind in the class I orientation (2, 16, 18). Although SH3 domains
share ~30% amino acid similarity, and a common fold, the ability to
predict the peptide recognition specificity of any given SH3 domain has
been challenging.
Over the past few years, several groups have used combinatorial peptide
libraries to characterize the recognition specificity of protein
interaction modules (reviewed in Ref. 19). We have generated an SH3
repertoire by modulating the chemical characteristics of the ligand
binding surface of a specific SH3 scaffold. We have then used this
repertoire to characterize potential evolutionary pathways that would
change the domain recognition specificity. Finally, we have exploited
the information obtained from the characterization of SH3 domains that
bind to two specific peptides to produce a position specific scoring
matrix and to develop an algorithm that permits to infer the molecular
recognition properties of SH3 domains.
Phage, Plasmids, and Fusion Proteins--
The Lambda vector,
used for the display of the SH3 repertoire, was derived from Library Construction--
To assemble a hybrid sequence encoding
an Abl SH3 domain with a discrete, degenerate codons, we designed a set
of partially overlapping oligonucleotides, whose sequences are reported
here: R287, CCACCCACGAATTCAACCTGTTCGTT; R286,
GCTCTGYWCGACTWCGTTGCTVNSRNSVVSRVSRMSCTGTCCATCACCAAAGGT; R288,
GAAAAACTGCGTGTTCTGGGTTACRVCCACAACGGTRRSTGGTGCGAAGCTCAG; R277,
GTTCCGTCCAMCTWCATCACCCCGGTGGATCCTCTCCGCC; R278,
AGCAACGWAGTCGWRCAGAGCAACGAACAGGTTGAATTCGTGGGTGG; R279,
GTAACCCAGAACACGCAGTTTTTCACCTTTGGTGATGGACAG;
R280,
TGATGWAGKTGGACGGAACSHMACCCTGACCGTTTTTGGTCTGAGCTTCGCACCA; and R289, GGCGGAGAGGATCCACCGGGG.
Sequence symbols are according to IUPAC format: W = A, T; R = A, G; M = A, C; Y = C, T; N = G, A, T, C; S = C, G;
H = A, C, T; K = G, T; V = A, C, G. The oligonucleotides
were phosphorylated at their 5' termini with T4 polynucleotide
kinase and the hybrid gene assembled by raising the temperature
to 94 °C and then slowly cooling down to 37 °C. The partially
assembled gene was amplified by polymerase chain reaction using primers
R314 (CCACCGACACTAGTAATGACCCCAACCTTTTCG) and R344
(GCGCATGCGCGGCCGCGACTGTTCACCGGGGTGATGWA), which contain SpeI
and a NotI sites, respectively. After amplification, the DNA
was digested with SpeI and NotI restriction
enzymes and purified using the QIAquick-spin PCR purification kit
(Qiagen). Two micrograms of SpeI/NotI-digested
L14 DNA were ligated to 10-30 ng of purified insert. The ligation
mixture was packaged using a Lambda packaging kit (Amersham
Biosciences, Inc.) and plated with Escherichia coli BB4 on
Luria broth (LB) plates, containing 10 mM MgCl2
and 0.2% maltose. After 8 h at 37 °C, phage particles were
recovered by adding 10 ml/plate of SM (10 mM Tris-HCl, 0.2 M NaCl, 5 mM MgCl2) and eluted for
3 h at 4 °C. The complexity of the library (number of
independent clones) was 107 plaque forming units (pfu), and
the titer of the eluted phages was about 1010 pfu/ml.
Affinity Selection--
Affinity selections with poly-proline
peptides were performed in microtiter plates (Nunc) coated overnight a
4 °C with 5 µg/ml streptavidin (Sigma) in 100 µl of PBS (10 mM
Na2HPO4/KH2PO4 (pH 7.2), 150 mM NaCl). In these conditions ~0.4 µg of
streptavidin remain bound to the plastic well. The coated plates were
washed ten times with PBS-0.05% Tween 20 and incubated for 30 min at 25 °C with biotinylated peptides (10 µM in PBS).
Plates were washed again and blocked for 1 h at 25 °C with 4%
bovine serum albumin (BSA) in PBS. About 109 phage
particles from the library (i.e. ~100 library equivalents) were added to each well and incubated at 4 °C overnight. After five
washes with PBS-0.05% Tween 20, the selected phages were recovered by
adding 100 µl of BB4 cells in 10 mM MgSO4 and
incubating for 30 min at 37 °C. The infected cells were then plated
with additional indicator bacteria and top agar and grown overnight at
37 °C, and phage were eluted as described above. After titrating the
number of phage particles in the phage suspension, the selection cycle
was carried out for two more times.
Plaque Assay--
Phage plaques from each selection round were
transferred onto nitrocellulose membranes by overlaying the membrane
onto the top agar of the Petri plate and by incubating for 4 h at
37 °C. Filters were blocked for 2 h at room temperature in PBS
containing 4% BSA. Biotinylated peptides were bound to
streptavidin-alkaline phosphatase (Sigma Chemical Co.) for 30 min at
room temperature and incubated with filters at 4 °C overnight. After
five washes with PBS-0.05% Tween, positive plaques were revealed by a
colorimetric reaction using nitro blue tetrazolium and
5-bromo-4-chloro-3-indolyl phosphate as substrates (Sigma).
ELISA--
ELISA assays were performed in microtiter plates
(Nunc), coated with biotinylated peptides as described above. Positive
plaques were collected and used to prepare plate lysates. Phages were eluted from a 6-cm plate with 2 ml of SM buffer and precipitated with 1 volume of 20% polyethylene glycol-2.5 M NaCl for 1 h
on ice. After centrifugation, the pellet was resuspended in 100 µl of
SM buffer and 10 µl of suspension, containing about 107
phages in 100 µl of PBS-4% BSA, was added to each microtiter well.
After 10 washes with PBS-0.05% Tween 20, plates were incubated with an
anti-lambda polyclonal antibody for 1 h at room temperature and
then with an anti-rabbit alkaline phosphatase-conjugated antibody (Sigma). Retention of the phage particles in the microtiter plate wells
was revealed by adding 100 µl/well of a 1 µg/ml solution of
p-nitrophenyl phosphate in 50 mM
NaHCO3, pH 9.6, 20 mM MgCl2.
To compare the binding strength of different GST-SH3 proteins,
microtiter wells, which had been coated with biotinylated peptides as
described above, were incubated with serial dilutions of fusion proteins in PBS-4% BSA for 2 h at 4 °C. After 10 washes, a
goat polyclonal anti-GST serum (Amersham Biosciences, Inc.) was added in PBS-4% BSA for 1 h at room temperature, followed by incubation with anti-goat Ig antibodies conjugated to alkaline phosphatase (Sigma). The reaction was revealed as described above. Data were fitted using a single class of an equivalent binding site equation.
Site-specific Mutagenesis--
Mutant Abl-SH3 coding
sequences were assembled from two overlapping DNA fragments obtained by
PCR amplification with pairs of complementary primers, each carrying
the mutated sequence, and two primers that prime from the 5'- and
3'-ends of the wild type SH3 domain sequence. This latter pair of
primers, which were common to all the mutagenesis experiments, contain
BamHI and EcoRI restriction sites, respectively,
for directional cloning into the pGEX2T vector; their sequences are:
R596,GGCAGCTAGGATCCAATGACCCCAACC, and R597,
GGACGAGTGAATTCCACTGTTGACTGG. The mutagenic primers used in the first
PCR amplification step were: R599,
AGTTATGCTTAGGTCGTTATCTCCACTGGC and R598,
AGTGGAGATAACGACCTAAGCATAACTAAAG for T79D; R618,
GTCTTAGGCTATTGTCACAATGGGGAATG and R619,
ACACCATTCCCCATTGTGACAATAGCCTAAGAC for N94C; R620,
CAAAAATGGCCAAGGCTATGTCCCAAGCAAC and R621,
GTAGTTGCTTGGGACATAGCCTTGGCCATT for W110Y; R764,
CAAAAATGGCCAAGGCTTGGTCCCAAGCAAC and R765, GTAGTTGCTTGGGACCAAGCCTTGGCCT
for W110V; R766, CAAAAATGGCCAAGGCGTGGTCCCAAGCAAC and R767,
GTAGTTGCTTGGGACCACGCCTTGGCCT for W110L.
Design of an SH3 Repertoire--
As a scaffold for our general
repertoire, we chose a well-characterized SH3 domain, the one of the
human protein kinase Abl, whose structure in complex with the peptide
ligand APTMPPPLPP (1Abo) has been determined at high resolution by
x-ray crystallography (23). Inspection of the three-dimensional
structure of the complex permitted the identification of the residues
within the SH3 domain that make contact with the ligand and were,
therefore, likely to be involved in determining its recognition
specificity. To identify the positions to diversify within this
scaffold, we aligned 560 different eukaryotic SH3 domains, whose
sequence was available in the PFAM data base (24) when we
started the project, and determined the frequency of occurrence of each
amino acid residue at each position that potentially contact its
ligand. Finally we designed a hybrid gene that encodes the Abl SH3
domain but has a degenerate sequence in the codons for the contact
residues. The extent of the degeneracy at each position is a compromise between the desirability of obtaining a repertoire that includes all
the residues that are found at those positions in natural SH3 domains
and the necessity of maintaining the size of the repertoire within the
limits set by the transformation efficiency of E. coli. Although the theoretical complexity of the repertoire is ~2 × 109, complete coverage was not possible because of the
design limitations imposed by the genetic code; however, the repertoire
includes at least 90% of the natural variability at each contact position.
The library of variant Abl SH3 domains was generated in bacteriophage
lambda (25). The coding region for the domain was fused to the carboxyl
terminus of the D capsid protein, which tolerates inserts and exists at
~400 copies on each virus particle. Ten million recombinants were
created, representing ~1% of the theoretical size of the repertoire.
By sequencing random isolates, we confirmed that 60% of the clones
contain in-frame fusions of the D and SH3 domain coding regions and
that the SH3 domains display random combinations of the allowed
residues at the degenerate positions.
Selection of SH3 Domains That Bind to Two Different
Peptides--
Because the SH3 domains in the repertoire are expressed
on the surface of bacteriophage lambda, ligands for any kind of
poly-proline peptide can be screened by a plaque lift assay or selected
by panning with a target peptide (26). We first asked whether, by these
techniques, we could recover from the library SH3 domains that would
bind to the peptide APTYPPPLPP (Abl-pep), which is a high affinity
ligand of the Abl-SH3 domain (27). Although the percentage of clones in
the library that binds to Abl-pep is less than 0.1%, after one or two
panning cycles, ~1 and 25% of the clones display an SH3 domain that
binds with apparent affinity that is comparable to the one of the wild
type SH3 domain (data not shown). Binding is specific, because the vast
majority of the selected clones do not bind to a peptide ligand
(LSSRPLPTLPSP; Src-pep) for the human Src SH3 domain (Fig.
1A) (18, 28).
Comparison of the residues that are present or missing at specific
degenerate positions of the domains selected after two panning cycles
(Fig. 1A) permits one to identify the requirements for
binding of an SH3 domain to the Abl-pep probe. Some of the degenerate
positions did not show any residue preference within the limits of the
variability engineered in the repertoire; for instance, at positions 70 and 115, tyrosine and phenylalanine are equally acceptable. By
contrast, at position 110, of the 9 residues tested at this position,
only tryptophan is found in the SH3 domains selected with the Abl-pep.
Interestingly, the threonine present at position 79, which flanks the
P-3 peptide binding site and was previously identified as a key residue
in determining the preference for a tyrosine instead of a positively charged residue at P-3 (16), can be replaced by a glutamate (but not
aspartate) in the SH3 domain scaffold without destroying binding.
Next, we asked whether the SH3 repertoire contained domains that would
bind to an unrelated peptide that is normally recognized by a different
class of SH3 domains. For this purpose we selected the peptide
sequence, LSSRPLPTLPSP
(Src-pep), which efficiently binds to SH3 domains of the Src family
(i.e. Src, Yes, Fyn). The SH3 domains of these
protein-tyrosine kinases are only 30% similar in primary
sequence to the SH3 domain of Abl and contain an n-Src loop that is one
residue shorter than in Abl. After three rounds of affinity selection,
we could identify SH3 domains that bind to Src-pep, although at a much
lower frequency than observed with the Abl-pep. Sequence analysis of
the isolates revealed that all, but one, had a Cys residue at position
94. Interestingly, this residue was not included in the original
repertoire design, because it is not present in any natural SH3 domain,
and thus this codon likely resulted from errors in oligonucleotide synthesis.
The residues that are enriched with respect to the unselected
repertoire in the two panning experiments can be compared in Fig.
2 where the font size is proportional to
the enrichment factor for each residue in each degenerate position.
Residues that, although included in the original repertoire design, are
never found in the selected domains are in reverse color.
This comparison reveals more or less subtle differences whose
rationalization is not always straightforward. The residues forming the
two hydrophobic pockets that host the PXXP motif do not
display a high selectivity when tested with the two peptides used in
this experiment. At positions 70 and 115 both Src-pep and Abl-pep
ligands preferentially display a Tyr. However, also the other residues
(His and Phe) allowed by the repertoire design are accepted,
irrespective of the ligand considered, albeit at a lower frequency. At
position 98 both peptides prefer negative residues and do not tolerate
positive ones. Finally, a certain degree of selectivity is determined
by the identity of the amino acids at position 114 in the 3/10 helix
preceding the
However, the most striking differences, emerging from the comparison of
the amino acid sequences of the two families of the selected domains,
involve residues that flank the third hydrophilic pocket, which hosts
the amino side of class I peptides; namely, residue 110 that is only
Trp in Abl-pep ligands and residue 94 that is a Cys in the vast
majority of the SH3 domains selected for binding to the Src-pep.
Finally, as already pointed out, position 79 is a major determinant for
the selection of the residue at position P-3 in the poly proline
peptide with Thr favoring hydrophobic and aromatic residues and Asp
determining the preference for a positively charged residue.
Characterization of the Molecular Determinants of Peptide
Recognition Specificity--
From the two selection experiments
described above, we have identified positions 79, 94, and 110 within
the scaffold of the Abl SH3 domain to be the major determinants that
discriminate between binding to the Abl and Src peptide ligands.
However, this approach cannot exclude that other residues or
combination of residues may play an important, albeit less prominent,
role. To ascertain how few of these residues should one change to
reverse the Abl SH3 ligand specificity, we constructed a series of
site-directed mutations by changing residues 79, 94, and 110 in the
wild type Abl SH3 domain. (For simplicity, these mutant domains will be referred to by three-letter code such that the three letters correspond to the residues at position 79, 94, and 110, respectively.) The mutant
domains were expressed as fusions to the glutathione
S-transferase (GST) protein, and their ability to bind
different peptides was evaluated by ELISA. As seen in Fig.
3A, as few as two amino acid replacements, either at positions 79 and 94 or 94 and 110, are sufficient to switch the peptide ligand preference of the Abl SH3
domain. By changing the three residues into TCL or TCV the binding
propensity is completely reversed and the apparent affinity of the two
mutant peptides becomes comparable to that of an SH3 domain of Src
(Fig. 3B).
The characterization of the domains selected from the SH3 repertoire
for their ability to bind to Abl-pep or Src-pep was not sufficient to
establish a correlation between specific residues in the SH3 binding
surface and the preference for specific residues at a given position
within the ligand peptide. To this possibility, we have performed a
complementary set of experiments by selecting peptide ligands from a
phage-displayed combinatorial 9-mer peptide library using as baits GST
fusions to the wild type Abl-SH3 domain and five variants carrying one
two or three mutations at positions 79, 94, and 110. The six GST
fusions all select peptides containing the PXXP consensus,
thereby confirming that the changes that we have introduced do not
affect the preference for the typical SH3 recognition motif (Fig.
4). The wild type SH3 domain of Abl,
which has residues TNW at these three positions, prefers peptide
ligands that have an aromatic side chain at P-3 and a Pro or a Phe at P-5. Although, the DNW mutant did not discriminate between
the Abl-pep and a peptide derivative in which the Tyr was changed into
an Arg (Fig. 3A) from the peptide selection experiment, it is clear that replacement of the Thr residue with an Asp at position 79 in the Abl SH3 domain scaffold favors the selection of peptide ligands
with an Arg at P-3. This preference is a characteristic of all the
domains that have Asp at 79. The TCW mutant
(i.e. Cys in place of Asn at position 94) has a dramatically
altered ligand specificity and selects peptides with Arg at P-5 and a
Leu at P-1. In the double mutant, DCW, the selected peptides match the specificity of the Src SH3 domain, with Arg at P-3 and Leu at P-1 in
the consensus. Finally, by substituting W110 with a smaller residue in
the triple mutants DCY and DCV, the selected peptides also prefer Pro
at P-2. In conclusion, this set of experiments has permitted to
identify a strong correlation between the Cys at position 94 in the SH3
domain and the Leu at position P-1 in the ligand peptide. Furthermore,
the substitution of the Thr at 79 with an Asp shifts the preference for
peptides that have a hydrophobic side chain at P-3 to peptides that
have an Arg at the same position. Collectively, these results
contribute to characterize a number of potential evolutionary
pathways leading, via three single point mutations, from an SH3 domain
that binds to APTYPPPLPP and not to LSSRPLPTLPSP, to a second SH3
domain with opposite specificity (Fig.
5).
The SH3 Profile Method to Infer the Recognition Specificity of the
Yeast SH3 Domains--
We have recently shown that the
consensus ligand peptides obtained by panning synthetic
peptide libraries with SH3 domains can be used to develop
position-specific scoring matrices that have a high predictive value in
the identification of the physiological partners of SH3 containing
proteins (22). The results presented in this manuscript provide
complementary information in that they permit the identification of a
consensus "SH3 binding surface" for recognition of a
specific poly-proline peptide.
Thus we have used the information contained in the multiple sequence
alignment of Fig. 1 to define, for any peptide ligand, a
position-specific surface profile that characterizes SH3 domains that
bind to that peptide. In the hypothesis that these profiles are
scaffold-independent, they could be used to infer the recognition specificity of any uncharacterized SH3 domain.
We define the peptide-specific SH3 profile as a 12 × 20 matrix,
where the twelve rows represent the twelve degenerate positions in our
repertoire and the twenty columns the twenty amino acids. Each position
of the matrix contains the ratio between the frequencies of the
corresponding residue at that surface position in the selected and
unselected repertoires. A peptide-specific score can then be assigned
to any given SH3 by adding, for each of the twelve SH3 positions, the
figure in the profile corresponding to the residue that is present at
that position in the query SH3.
We have applied our scoring profile on the entire set of SH3 domains
present in the baker's yeast, Saccharomyces cerevisiae, by
ranking the 29 SH3 domains of this organism according to the probability that they would bind to the Abl-pep or to Src-pep (white bars in Fig. 6). To
test these predictions, we overexpressed 24 of the domains as GST
fusion proteins and examined binding to the peptides in an ELISA.
Interestingly, the SH3 profile method correctly ranks in the top three
positions the three SH3 domains, Abl-SH3, Myo5-SH3, and Myo3-SH3, that
efficiently bind to the Abl-pep. On the other hand, although the
Src-pep profile correctly ranked, among the six most probable ligands,
five yeast domains that experimentally were found to bind to the
Src-pep, the SH3 domain of Abp1 scored as a false positive. Furthermore
the SH3 domain of the protein H_cSrc is not predicted among the
best ligands. This is possibly a consequence of the oversimplification
of the method that requires the sequences of the SH3 domains to be
aligned also in regions that corresponds to loops of different length. The n-src loop of the SH3 domain of kinases of the Src family is one
residue shorter than the one in Abl. Notwithstanding this limitation,
by using the profiles derived from the screening of the present
repertoire, we have correctly identified the yeast SH3 domains that
bind to Abl-pep and to Src-pep, and we have only erroneously included
Abp1 among the yeast domains that bind to Src-pep. Similar results were
obtained by using a Hidden Markov Model approach (not shown). To
evaluate the statistical significance of the prediction, we have
generated 100 random profiles by simulating 100 different panning
experiments. We have then used these profiles to rank the yeast SH3
domains, and we have compared the predictions with those obtained with
the experimentally derived profiles. While the experimental profile
ranks four SH3 ligands in the top four positions in the case of
Src-pep and three in the top three for Abl-pep (Fig. 6), on average the
mock profiles rank 1.3 (Src-pep) and 0.3 (Abl-pep) experimentally
verified ligands in the top four positions, the best performance being
positions three and one, respectively.
Thus, despite billions of years of evolution, the same function
(binding to Abl-pep or to Src-pep) is associated to protein surfaces
that can be identified, with sufficient confidence, by a profile
derived by an in vitro evolution experiment of our synthetic repertoire.
A Repertoire of SH3 Binding Surfaces That Is Similar to the Natural
Repertoire--
We have designed and assembled a repertoire of SH3
domains by grafting different combinations of the residues observed in the ligand binding pockets of natural domains onto the scaffold of the
Abl-SH3 domain. This repertoire was used to search for elements that
bind to several poly-proline peptides (some of these selections have
not been described in this report). Similar, although more limited
repertoires, were used to select PDZ (9), SH3 (28), and WW (10) domains
that would bind more tightly to specific peptide ligands or to new
peptide ligand sequences. Our repertoire, by contrast, was designed
with the aim of representing the entire binding potential of natural
SH3 domains. This goal was obtained by building a degenerate Abl-SH3
gene that would encode in the 12 positions involved in target
recognition most of the residues that are found, at the corresponding
location, in natural SH3 domains. Thus most residue combinations that
would result in unfolded molecules or non-functional binding surfaces are not contained in the repertoire. Furthermore, our synthetic repertoire of 107 different molecules represents most of
the sequence and structure space clustered around the ensemble of
natural SH3 domains. As a consequence, most of the SH3 binding surfaces
that have been explored by natural evolution are likely to be
represented. In fact, by panning with a variety of peptides containing
the PXXP SH3 binding motif, we have always been able to find
ligands (unpublished experiments). It would be interesting to ask
whether such a repertoire also contains elements that would bind to
less typical SH3 targets as recently described for several natural SH3
domains (29-31).
Evolutionary Pathways--
In vitro screening and
selection of peptide repertoires is a powerful tool for answering
fundamental questions regarding the evolution of protein properties
(32-34). To be able to identify potential evolutionary pathways of
recognition specificity, we have chosen two distantly related
poly-proline peptides that bind SH3 domains of the Abl and Src families
with very different binding constants. By screening the SH3 repertoire
with the two distinct peptide ligands, we have characterized SH3
domains representing possible intermediate steps in short evolutionary
pathways that, with as few as two or three amino acid substitutions on
the surface of the domain can switch the preference of the SH3 domain
between the ligands (Fig. 5). These results provide a clear and
well-defined example of how different specificities can evolve in
protein interaction.
In one scenario (Fig. 5A, pathway 1), we envision
that the specificity of the TNW SH3 domain, which efficiently binds to
Abl-pep but not to Src-pep, can be first mutated to TCW without
substantially changing its recognition properties. A second
substitution, TCL, then causes a sudden shift in ligand preference,
which is refined by a third amino acid substitution (DCL). In a second
scenario (Fig. 5A, pathway 3), the shift from
Abl-pep to Src-pep binding is first mediated by a mutation (TNV) that
leads to a non-functional domain; the TNV domain weakly binds to both
peptides and fails to select peptides from our combinatorial peptide
libraries (data not shown). Finally, in a third scenario, pathway
2 can be considered an example of co-evolution of the two binding
partners, because each domain along the pathway has a different
preferred peptide and one can conceive that the selection of SH3 domain
variants is driven, at each step, by corresponding changes of the
poly-proline peptide partner or vice versa (Fig.
5B). Thus, the evolution of different SH3 domain
specificities can be driven by very simple evolutionary pathways
involving only a few amino acid changes in the SH3 domain. We suggest
that this property characterizes small domains involved in protein
recognition and that it represents one of the main reasons for their
success during evolution and for fixation in the proteome.
Binding Specificity--
By selecting the preferred ligands of
many SH3-Abl variants, we have determined some "soft" rules that
hint to the existence of a recognition code, which, however, is highly
degenerate and context-dependent. For instance, Asp at
position 79 of the SH3 domain selects for peptides that display Arg at
P-3, but Src-pep with an Arg at P-3 binds to SH3 domains irrespective
of whether they have Asp or Glu at that position. On the other hand,
Abl-pep with a Tyr at P-3 tolerates both Thr and Glu (but not Asp) at position 79. One highly conserved residue in the SH3 domains that is
selected from the repertoire for binding to Abl-pep is the Trp at 110, which is involved, together with Trp-99, in the formation of a
hydrophobic pocket that hosts the Pro at P-5 in the target peptide.
Also striking is the preference for Cys at position 94 in SH3 domains
that bind to Src-pep. By selecting the preferred ligands of SH3-Abl
variants that contain Cys-94, we have observed a correlation between
the presence of this residue in the SH3 domain and Leu at P-1 in the
ligand peptide. We have demonstrated that Cys-94 forms a disulfide
bridge with Cys-100 in the Abl SH3 scaffold (not shown), most likely
resulting in a distortion of the n-Src loop and possibly in the
formation of a larger, and hydrophobic, cavity that can host the Leu at
P-1 in the peptide. The correlation between Cys-94 in the SH3 domain
and Leu at P-1 in the peptide is scaffold-dependent and
cannot be used to infer the recognition specificity of a different SH3 domain.
Some other preferences have been detected by our experiments: For
instance most SH3 domains that bind to Src-pep have an Asn at position
114, whereas Abl-pep enriches for a Thr at that position. Similarly,
Phe or Tyr at position 72 are preferentially found in domains that bind
to Abl-pep and Src-pep, respectively.
Inferring Recognition Specificity--
Several reports have
convincingly shown that the consensus ligand obtained by panning
peptide repertoires with protein binding modules have a high predictive
value when used, as templates in computer searches, to identify the
natural partners of the domains (for a review see Ref. 19). Our
approach addresses a complementary question and permits one to identify
the characteristics of the domain binding surface for any given target
peptide (in this specific case a poly-proline peptide). In the work
reported here, we have asked whether the "binding information"
obtained by screening artificial domain repertoires could be used to
identify, in a proteome, those SH3 domains that are likely to bind to a
specific poly-proline peptide. Because many protein interactions are
mediated by small protein recognition modules, the development of a
reliable predictive algorithm would permit one to infer a large
fraction of the interaction network with a limited set of experiments. A difficulty in this approach may arise from the implicit assumption that the chemical characteristic of the binding surfaces are largely scaffold-independent and that the information extracted from Fig. 2 can
be compared with any SH3 domain, whatever the characteristics of its scaffold.
Despite the correlations uncovered by our experiments, however, it has
not been possible to find a simple set of rules that would permit one
to establish whether any given SH3 domain in our repertoire would bind
to Abl-pep or Src-pep. Nevertheless, we asked whether a
position-specific scoring matrix, based on the amino acid frequencies
observed in the domains selected from the SH3 artificial repertoire,
could be used to rank natural domains according to the probability that
they would bind to the poly-proline peptide used in the selection
experiment. We have named this scoring matrix a "peptide-specific
profile." This is a rather naive approach, because it neglects the
contribution to binding of the residues that do not make direct contact
with the target peptide but still may have an influence on binding
affinity. We have tested this simple approach by asking which of the 29 SH3 domains in the yeast proteome have the potential to bind Src-pep
and Abl-pep, and we have compared the prediction with the experimental
results obtained by ELISA. The comparison shows that the Abl-pep
profile performs satisfactorily, because the two yeast SH3 domains
(Myo5-SH3 and Myo5-SH3), which are experimentally found to bind to
Abl-pep, obtained the highest score. Also the prediction obtained by
the Src-pep profile successfully identified the yeast SH3 domains (Rvs167, Yhr016, Yfr024, Yhr114_2 and Sla1_3) that bind to Src-pep. However, the human Src-SH3 domain itself obtains a score that is worse
than the yeast Abp1 domain, which does not bind to Src-pep in ELISA.
False negatives, like Src-SH3, could represent a "solution" to the
binding problem that is different from the one that is prominent in our
artificial repertoire. As mentioned above, both false negative and
false positives could arise, because the underlying scaffold has a
stronger influence than assumed in our approach. We have recently
solved the three-dimensional structure of the Abp1 SH3 domain and, by
site-directed mutagenesis, we have been able to prove that the Glu
residue at position 69 has a strong influence on ligand preference,
because an Abp1 SH3 mutant having a Leu at that position, differently
from wild type, binds efficiently to Src-pep (35). Position 69 was not
randomized in our repertoire, and, as a consequence, it does not
contribute to the profile score. Because this residue does not make
contact with the ligand, its influence on recognition specificity
represents a clear example of a context effect in ligand binding.
The influence of the scaffold on target binding is particularly evident
in the preference for Cys at position 94 in the Src-pep selection.
Cys-94 forms a disulfide bridge with a second Cys that is present in
the Abl scaffold. Because the formation of the disulfide bridge is
essential for binding to Src-pep (not shown), it is unlikely that the
presence of a Cys at that position in most other natural scaffolds,
which do not have a Cys corresponding to Cys-100, would favor binding
to Src-pep. Another difficulty arises from the uncertainty in aligning
loops of different length. We suspect that our prediction for Src-pep
binding peptides would have performed better if we had designed our
peptide repertoire with an n-Src loop one amino acid shorter, as
observed in most SH3 domains of the Src kinase family. Despite all
these limitations, we have been able to show that position-specific
scoring matrices, calculated from the frequency of occurrence of
residues at 12 positions of the binding surface of a combinatorial
repertoires, are rather powerful tools to infer the binding preference
of SH3 domains.
This Repertoire Can Be Used as a Source of Perturbagens--
The
107 structures that form our SH3 domain repertoire
represent a unique source of molecules that can be used to search for affinity reagents to any target protein. Several authors have assembled
combinatorial peptide repertoires displayed on different scaffolds and
showed that these repertoires can be used to select ligands
(perturbagens) that, by binding to intracellular protein targets,
interfere with physiological pathways (36-39). This is a powerful
approach to dissect cellular pathways. It is unlikely, however, that
repertoires of this size and structure will be comprehensive and
represent a source of ligands for any protein. An approach that is
alternative to a single large and general repertoire would consist in
the assembly of a collection of specialized repertoires each aimed at a
more restricted region of the structural space. For instance, a
repertoire that aims at peptides with a free carboxyl terminus (based
on the PDZ scaffold) (9) or a second one that aims at peptides
phosphorylated in Tyr (based on an SH2 scaffold) (40). We have shown
that our SH3 repertoire contains elements that can bind to a variety of
poly-proline peptides. The SH3 domain repertoire is directed to
the many proteins (~50% of the yeast proteins) that display on their
surface peptides that contain the PXXP signature of an SH3
ligand. Because often these peptides are used in signal transduction
pathways to assemble signaling complexes via interaction with WW or SH3
domains, it is anticipated that a sizeable number of ligands targeted
to these structures will disturb functional pathways.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
pRH825
(20) by deletion of an XbaI fragment. This deletion removes
one of the two LoxP sites and the entire plasmid DNA. Like
the original vector, this derivative has a second copy of the
D gene, but includes at its 3'-end two sites,
SpeI and NotI, that can be used for the insertion
of DNA fragments (21) and is more stable (i.e. the second
D gene is not deleted after several growth cycles). The
constructions of the GST-SH31
fusion plasmids expressing yeast SH3 domains have
been described elsewhere (22).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (37K):
[in a new window]
Fig. 1.
Primary structure of the SH3 domains that
bind to two types of proline rich peptides. A,
underlined is the amino acid sequence of the SH3 domain of
the human Abl tyrosine kinase. Above this sequence, we list the
residues that were allowed in each corresponding position in the design
of the degenerate Abl-SH3 coding region. Numbers refer to
residue positions in the Abl protein. Below the Abl-SH3 sequence, we
report the residues that were observed in the degenerate positions in
the SH3 domains, which were selected for binding to the APTYPPPLPP
peptide (Abl-pep). B, as in A, but the reported
sequences correspond to SH3 domains that were selected for binding to
the LSSRPLPTLPSP peptide (Src-pep). The selected domains were tested,
in an ELISA format, for binding to biotinylated Abl-pep or to Src-pep
that had been immobilized on streptavidin-coated microtiter plate
wells. The strength of binding in the wells is depicted on the
right with a gray intensity scale. The
arrow diagram in the lower part represents the
five-stranded
structure of SH3 domains.
5 strand and in residue 72, which participates in the
formation of the central pocket. At position 114, Thr favors the
interaction with the Abl-pep whereas an Asn determines the preference
for the Src-pep. Note that the wild type Abl-SH3 domain has an Asn at
this position. By contrast, at position 72, the Abl and Src peptides
favor Phe and Tyr, respectively.

View larger version (57K):
[in a new window]
Fig. 2.
Schematic representation of the relative
abundance of the residues observed at each degenerate position of the
SH3 repertoire in the two selection experiments. In each
gray box, corresponding to the twelve degenerate
positions of the SH3 repertoire, the font size is
proportional to the relative frequency of the specific residue in the
selected versus the unselected repertoire. Residues that
were never observed in the sample of selected domains, which were
characterized in this work, although present in the repertoire design,
are in reverse color. The amino acid frequencies were
calculated from the data in Fig. 2, and the corresponding
boxes are depicted on a surface representation
(colored for charge) of the Abl SH3 domain. Positions that
showed a marked difference in the two experiments are framed in
red.

View larger version (35K):
[in a new window]
Fig. 3.
Solid phase assay. A, four
different biotinylated peptides (10 µM) were adsorbed to
a microtiter wells, which had been previously coated with 5 µg/ml
streptavidin. 0.3 µg of a mutant Abl-SH3 domain (fused to GST) was
added to each well, and its binding was monitored by probing with
polyclonal anti-GST goat serum and an anti-goat
alkaline-phosphatase-conjugated antibody. The amino acid sequences of
the peptides used in the assay are reported to the right of
the histogram. The mutant domains are indicated with a three-letter
code according to the residues present at position 79, 94, and 110. Abl-pep-YR is an Abl-pep derivative in which the Tyr at position
3
has been substituted by an Arg. Src-pep II, a typical class II peptide,
is used as a control in this experiment. B, binding of four
different SH3 domains was probed, as in A, at different
domain concentrations. In this experiment the wells were coated with a
peptide concentration of 0.1 µM. Each data point is the
average of two independent measurements that did not differ by more
than 10%.

View larger version (41K):
[in a new window]
Fig. 4.
Preferred ligands of the different SH3 domain
mutants. Six SH3 domains were used to select by affinity a
combinatorial peptide library of 9-mers displayed on the surface of the
filamentous phage M13. After three rounds of selection, the binding of
the selected clones was confirmed by ELISA and then sequenced to
determine the amino acid sequence of the displayed peptides. The
peptides are aligned, with the consensus sequence reported
below each alignment. Whenever a residue is conserved in
more than 90% of the peptides, it is indicated with a capital
letter in the consensus, whereas residues that are conserved in
more than 50% of the clones are in small letters. @ stands
for an aromatic residue.

View larger version (33K):
[in a new window]
Fig. 5.
Schematic representation of potential
evolutionary pathways. A, each mutant Abl SH3 domain is
represented as a rectangle. The domains that are linked by a
single mutational event are joined by a line. The apparent
affinity of each domain for Abl-pep and Src-pep, as deduced from the
experiment in Fig. 4, is represented in a gray intensity
scale on the right and left side of each
rectangle, respectively. Representative evolutionary
pathways, described in the main text, are labeled with
numbers. B, details of the pathway labeled
2, representing the co-evolution of the SH3 specificity
pocket and the sequence of the preferred ligand.

View larger version (38K):
[in a new window]
Fig. 6.
The SH3 profile method. Two different
profiles were constructed for the peptides APTYPPPLPP (Abl-pep) and
LSSRPLPTLPSP (Src-pep), respectively. A profile is a peptide-specific
12 × 20 matrix that contains, for each of the twelve degenerate
positions in the SH3 repertoire, the frequency of occurrence of the
twenty amino acids at that specific position in the pool of SH3
domains, which were selected for binding to that peptide. In the case
of the Abl-pep probe, we have used the data in Fig. 1A. For
Src-pep, to increase the statistical significance of the approach, we
have added the sequence of six domains that have been selected with the
related peptide LSSRPLPTAPSP to the sequences of the
Src-pep-specific domains in Fig. 1B (not shown). The
profiles have been used to evaluate the propensity of each of 24 SH3
domains present in the S. cerevisiae proteome to bind either
Abl-pep or Src-pep. This was obtained by adding up, for each SH3
degenerate position, the frequency corresponding to the amino acid
present at that position in the SH3 domain under scrutiny. The scores,
for each domain, are reported in an arbitrary scale (white
bars). The filled bars represent the optical density
(OD) values obtained in an ELISA carried out as described in Fig.
4.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
| |
ACKNOWLEDGEMENT |
|---|
We thank B. Kay for comments and help in improving the manuscript.
| |
FOOTNOTES |
|---|
* This work was supported by grants from Associazione Italiana per la Ricerca sul Cancro, Target project biotechnology from CNR and the European Union Biotechnology project.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Present address: Dept. of Physiology and Biochemistry, University
of Pisa, Via Carducci, 56010 Pisa, Italy.
§ To whom correspondence should be addressed. Tel.: 39-06-7259-4315; Fax: 39-06-2023-500; E-mail: cesareni@uniroma2.it.
Published, JBC Papers in Press, April 19, 2002, DOI 10.1074/jbc.M109788200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: GST, glutathione S-transferase; pfu, plaque-forming units; PBS, phosphate-buffered saline; BSA, bovine serum albumin; ELISA, enzyme-linked immunosorbent assay.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Pawson, T.,
and Scott, J. D.
(1997)
Science
278,
2075-2080 |
| 2. |
Ren, R.,
Mayer, B. J.,
Cicchetti, P.,
and Baltimore, D.
(1993)
Science
259,
1157-1161 |
| 3. |
Moran, M. F.,
Koch, C. A.,
Anderson, D.,
Ellis, C.,
England, L.,
Martin, G. S.,
and Pawson, T.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
8622-8626 |
| 4. | Fanning, A. S., and Anderson, J. M. (1999) Curr. Opin. Cell Biol. 11, 432-439[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Sudol, M. (1998) Oncogene 17, 1469-1474[CrossRef][Medline] [Order article via Infotrieve] |
| 6. |
Songyang, Z.,
Gish, G.,
Mbamalu, G.,
Pawson, T.,
and Cantley, L. C.
(1995)
J. Biol. Chem.
270,
26029-26032 |
| 7. | Lee, C. H., Leung, B., Lemmon, M. A., Zheng, J., Cowburn, D., Kuriyan, J., and Saksela, K. (1995) EMBO J. 14, 5006-5015[Medline] [Order article via Infotrieve] |
| 8. | Stricker, N. L., Christopherson, K. S., Yi, B. A., Schatz, P. J., Raab, R. W., Dawes, G., Bassett, D. E., Jr., Bredt, D. S., and Li, M. (1997) Nat. Biotechnol. 15, 336-342[CrossRef][Medline] [Order article via Infotrieve] |
| 9. | Schneider, S., Buchert, M., Georgiev, O., Catimel, B., Halford, M., Stacker, S. A., Baechi, T., Moelling, K., and Hovens, C. M. (1999) Nat. Biotechnol. 17, 170-175[CrossRef][Medline] [Order article via Infotrieve] |
| 10. | Kasanov, J., Pirozzi, G., Uveges, A. J., and Kay, B. K. (2001) Chem. Biol. 8, 231-241[CrossRef][Medline] [Order article via Infotrieve] |
| 11. |
Ponting, C. P.,
Schultz, J.,
Milpetz, F.,
and Bork, P.
(1999)
Nucleic Acids Res.
27,
229-232 |
| 12. |
Kay, B. K.,
Williamson, M. P.,
and Sudol, M.
(2000)
FASEB J.
14,
231-241 |
| 13. | Mayer, B. J. (2001) J. Cell Sci. 114, 1253-1263[Abstract] |
| 14. | Musacchio, A. (2002) in How SH3 Domains Recognize Proline. Advances in Protein Chemistry (Janin, J. , and Wodak, S., eds) , p. 61, Academic Press, New York |
| 15. | Lim, W. A., Richards, F. M., and Fox, R. O. (1994) Nature 372, 375-379[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Musacchio, A., Saraste, M., and Wilmanns, M. (1994) Nat. Struct. Biol. 1, 546-551[CrossRef][Medline] [Order article via Infotrieve] |
| 17. |
Feng, S.,
Chen, J. K., Yu, H.,
Simon, J. A.,
and Schreiber, S. L.
(1994)
Science
266,
1241-1247 |
| 18. | Rickles, R. J., Botfield, M. C., Weng, Z., Taylor, J. A., Green, O. M., Brugge, J. S., and Zoller, M. J. (1994) EMBO J. 13, 5598-5604[Medline] [Order article via Infotrieve] |
| 19. | Kay, B. K., Kasanov, J., Knight, S., and Kurakin, A. (2000) FEBS Lett. 480, 55-62[CrossRef][Medline] [Order article via Infotrieve] |
| 20. | Santi, E., Capone, S., Mennuni, C., Lahm, A., Tramontano, A., Luzzago, A., and Nicosia, A. (2000) J. Mol. Biol. 296, 497-508[CrossRef][Medline] [Order article via Infotrieve] |
| 21. | Castagnoli, L., Zucconi, A., Quondam, M., Rossi, M., Vaccaro, P., Panni, S., Paoluzi, S., Santonico, E., Dente, L., and Cesareni, G. (2001) Comb. Chem. High Throughput Screen 4, 121-133[Medline] [Order article via Infotrieve] |
| 22. |
Tong, A. H.,
Drees, B.,
Nardelli, G.,
Bader, G. D.,
Brannetti, B.,
Castagnoli, L.,
Evangelista, M.,
Ferracuti, S.,
Nelson, B.,
Paoluzi, S.,
Quondam, M.,
Zucconi, A.,
Hogue, C. W.,
Fields, S.,
Boone, C.,
and Cesareni, G.
(2002)
Science
295,
321-324 |
| 23. | Pisabarro, M. T., Serrano, L., and Wilmanns, M. (1998) J. Mol. Biol. 281, 513-521[CrossRef][Medline] [Order article via Infotrieve] |
| 24. |
Bateman, A.,
Birney, E.,
Durbin, R.,
Eddy, S. R.,
Howe, K. L.,
and Sonnhammer, E. L.
(2000)
Nucleic Acids Res.
28,
263-266 |
| 25. |
Smith, G. P.
(1985)
Science
228,
1315-1317 |
| 26. | Zucconi, A., Dente, L., Santonico, E., Castagnoli, L., and Cesareni, G. (2001) J. Mol. Biol. 307, 1329-1339[CrossRef][Medline] [Order article via Infotrieve] |
| 27. | Pisabarro, M. T., and Serrano, L. (1996) Biochemistry 35, 10634-10640[CrossRef][Medline] [Order article via Infotrieve] |
| 28. | Sparks, A. B., Adey, N. B., Quilliam, L. A., Thorn, J. M., and Kay, B. K. (1995) Methods Enzymol. 255, 498-509[Medline] [Order article via Infotrieve] |
| 29. | Mongiovì, A. M., Romano, P. R., Panni, S., Mendoza, M., Wong, W. T., Musacchio, A., Cesareni, G., and Paolo Di Fiore, P. (1999) EMBO J. 18, 5300-5309[CrossRef][Medline] [Order article via Infotrieve] |
| 30. | Kang, H., Freund, C., Duke-Cohan, J. S., Musacchio, A., Wagner, G., and Rudd, C. E. (2000) EMBO J. 19, 2889-2899[CrossRef][Medline] [Order article via Infotrieve] |
| 31. |
Kato, M.,
Miyazawa, K.,
and Kitamura, N.
(2000)
J. Biol. Chem.
275,
37481-37487 |
| 32. | Hoffmuller, U., Knaute, T., Hahn, M., Hohne, W., Schneider-Mergener, J., and Kramer, A. (2000) EMBO J. 19, 4866-4874[CrossRef][Medline] [Order article via Infotrieve] |
| 33. | Altamirano, M. M., Blackburn, J. M., Aguayo, C., and Fersht, A. R. (2000) Nature 403, 617-622[CrossRef][Medline] [Order article via Infotrieve] |
| 34. | Keefe, A. D., and Szostak, J. W. (2001) Nature 410, 715-718[CrossRef][Medline] [Order article via Infotrieve] |
| 35. |
Fazi, B.,
Cope, M. J.,
Douangamath, A.,
Ferracuti, S.,
Schirwitz, K.,
Zucconi, A.,
Drubin, D. G.,
Wilmanns, M.,
Cesareni, G.,
and Castagnoli, L.
(2002)
J. Biol. Chem.
277,
5290-5298 |
| 36. |
Geyer, C. R.,
Colman-Lerner, A.,
and Brent, R.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
8567-8572 |
| 37. |
Blum, J. H.,
Dove, S. L.,
Hochschild, A.,
and Mekalanos, J. J.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
2241-2246 |
| 38. | Xu, X., Leo, C., Jang, Y., Chan, E., Padilla, D., Huang, B. C., Lin, T., Gururaja, T., Hitoshi, Y., Lorens, J. B., Anderson, D. C., Sikic, B., Luo, Y., Payan, D. G., and Nolan, G. P. (2001) Nat. Genet. 27, 23-29[CrossRef][Medline] [Order article via Infotrieve] |
| 39. |
Norman, T. C.,
Smith, D. L.,
Sorger, P. K.,
Drees, B. L.,
O'Rourke, S. M.,
Hughes, T. R.,
Roberts, C. J.,
Friend, S. H.,
Fields, S.,
and Murray, A. W.
(1999)
Science
285,
591-595 |
| 40. | Malabarba, M. G., Milia, E., Faretta, M., Zamponi, R., Pelicci, P. G., and Di Fiore, P. P. (2001) Oncogene 20, 5186-5194[CrossRef][Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
D. Grabulovski, M. Kaspar, and D. Neri A Novel, Non-immunogenic Fyn SH3-derived Binding Protein with Tumor Vascular Targeting Properties J. Biol. Chem., February 2, 2007; 282(5): 3196 - 3204. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Hosse, A. Rothe, and B. E. Power A new generation of protein display scaffolds for molecular recognition Protein Sci., January 1, 2006; 15(1): 14 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. G. Arias-Salgado, S. Lizano, S. Sarkar, J. S. Brugge, M. H. Ginsberg, and S. J. Shattil Src kinase activation by direct interaction with the integrin {beta} cytoplasmic domain PNAS, November 11, 2003; 100(23): 13298 - 13302. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ciarapica, J. Rosati, G. Cesareni, and S. Nasi Molecular Recognition in Helix-Loop-Helix and Helix-Loop-Helix-Leucine Zipper Domains. DESIGN OF REPERTOIRES AND SELECTION OF HIGH AFFINITY LIGANDS FOR NATURAL PROTEINS J. Biol. Chem., March 28, 2003; 278(14): 12182 - 12190. [Abstract] [Full Text] [PDF] |
||||
| ||||||||